Skip to main content

Advertisement

Table 4 Phenotype frequencies of HLA-ABDR alleles according to latency period

From: The association of human leukocyte antigen polymorphisms with disease severity and latency period in patients with silicosis

HLA alleles Short latency (n = 23 patients)** Long latency (n = 25 patients)** P= Mean
A1 5 (11.0%) 4 (8.0%)   NS*
A2 11 (24.0%) 11 (22.0%)   NS*
A3 4 (8.7%) 3 (6.0%)   NS*
A11 8 (17.4%) 8 (16.0%)   NS*
A23 1 (2.2%) 2 (4.0%)   NS*
A24 8 (17.4%) 15 (30.0%)   NS*
A26 2 (4.4%) 2 (4.0%)   NS*
A29 2 (4.4%) 1 (2.0%)   NS*
A30 4 (8.7%) 1 (2.0%)   NS*
A32 0 (0.0%) 2 (4.0%)   NS*
A33 1 (2.2%) 0 (0.0%)   NS*
A68 0 (0.0%) 1 (2.0%)   NS*
B7 3 (6.6%) 5 (10.0%)   NS*
B8 1 (2.2%) 2 (4.0%)   NS*
B13 3 (6.6%) 0 (0.0%)   NS*
B18 2 (4.4%) 1 (2.0%)   NS*
B27 1 (2.2%) 0 (0.0%)   NS*
B35 15 (32.7%) 15 (30.0%)   NS*
B37 1 (2.2%) 1 (2.0%)   NS*
B38 1 (2.2%) 0 (0.0%)   NS*
B39 1 (2.2%) 1 (2.0%)   NS*
B40 1 (2.2%) 3 (6.0%)   NS*
B41 2 (4.4%) 0 (0.0%)   NS*
B44 2 (4.4%) 2 (4.0%)   NS*
B49 2 (4.4%) 1 (2.0%)   NS*
B50 1 (2.2%) 1 (2.0%)   NS*
B51 8 (17.4%) 6 (12.0%)   NS*
B52 0 (0.0%) 3 (6.0%)   NS*
B54 0 (0.0%) 1 (2.0%)   NS*
B55 2 (4.4%) 3 (6.0%)   NS*
B57 2 (4.4%) 2 (4.0%)   NS*
B64 0 (0.0%) 1 (2.0%)   NS*
DR3 1 (2.2%) 5 (10.0%)   NS*
DR4 4 (8.7%) 8 (16.0%)   NS*
DR7 6 (13.1%) 2 (4.0%)   NS*
DR10 2 (4.4%) 2 (4.0%)   NS*
DR11 12 (26.2%) 11 (22.0%)   NS*
DR13 6 (13.1%) 5 (10.0%)   NS*
DR14 6 (13.1%) 5 (10.0%)   NS*
DR15 5 (11%) 9 (18.0%)   NS*
DR16 2 (4.4%) 5 (10.0%)   NS*
  1. *NS, Not significant; **Percentages were calculated according to the allele number.